The Clinical Spectrum and Outcome of Uveomeningitis: A Comprehensive Analysis of 110 Cases.


Journal

Ocular immunology and inflammation
ISSN: 1744-5078
Titre abrégé: Ocul Immunol Inflamm
Pays: England
ID NLM: 9312169

Informations de publication

Date de publication:
Aug 2022
Historique:
pubmed: 12 5 2021
medline: 19 11 2022
entrez: 11 5 2021
Statut: ppublish

Résumé

Uveitis can be associated with meningitis (uveomeningitis) and the inflammation shared with the central nervous system. We aimed to describe the characteristics and outcome of uveomeningitis. We retrospectively analyzed 110 consecutive adult patients with uveomeningitis. The main causes of uveomeningitis were Vogt-Koyanagi-Harada (31%), syphilis (16%), sarcoidosis (12%), Behçet's disease (7%), and multiple sclerosis (5%). Sixteen percent of uveomeningitis remained of undetermined origin. Compared to etiology-matched uveitis without meningitis, patients with uveomeningitis were younger, had more frequent neurological manifestations, and had more frequent abnormal cerebral magnetic resonance imaging findings. In contrast, no ocular feature upon examination was significantly associated with the presence of meningitis. Patients with uveomeningitis were more frequently treated with immunosuppressants but uveitis relapse and systemic complications did not differ between groups. Uveomeningitis is associated with a limited spectrum of diseases. Meningitis does not seem to impact ocular and extraocular outcomes. Therefore, lumbar puncture should be performed on an individual basis during the diagnostic workup of uveitis.

Identifiants

pubmed: 33974484
doi: 10.1080/09273948.2021.1898000
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1489-1494

Auteurs

Jérome Hadjadj (J)

Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, APHP-Centre Université de Paris (CUP), Paris, France.
Université de Paris, Paris, France.

Géraldine Gaube (G)

Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, APHP-Centre Université de Paris (CUP), Paris, France.

Matthieu Groh (M)

Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, APHP-Centre Université de Paris (CUP), Paris, France.
Department of Internal Medicine, Hôpital Foch, Suresnes, France.

Romain Paule (R)

Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, APHP-Centre Université de Paris (CUP), Paris, France.
Department of Internal Medicine, Hôpital Foch, Suresnes, France.

Sawsen Salah (S)

Department of Ophthalmology, Hôpital Cochin, APHP-CUP, Paris, France.

Florence Hoogewoud (F)

Department of Ophthalmology, Hôpital Cochin, APHP-CUP, Paris, France.
Jules Gonin Eye Hospital, FAA, University of Lausanne, Lausanne, Switzerland.

Philippe Blanche (P)

Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, APHP-Centre Université de Paris (CUP), Paris, France.

Luc Mouthon (L)

Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, APHP-Centre Université de Paris (CUP), Paris, France.
Université de Paris, Paris, France.

Dominique Monnet (D)

Université de Paris, Paris, France.
Department of Ophthalmology, Hôpital Cochin, APHP-CUP, Paris, France.

Claire Le Jeunne (C)

Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, APHP-Centre Université de Paris (CUP), Paris, France.
Université de Paris, Paris, France.

Antoine Brézin (A)

Université de Paris, Paris, France.
Department of Ophthalmology, Hôpital Cochin, APHP-CUP, Paris, France.

Benjamin Terrier (B)

Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, APHP-Centre Université de Paris (CUP), Paris, France.
Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH